Viewing StudyNCT00437242



Ignite Creation Date: 2024-05-05 @ 5:20 PM
Last Modification Date: 2024-10-26 @ 9:31 AM
Study NCT ID: NCT00437242
Status: TERMINATED
Last Update Posted: 2012-06-04
First Post: 2007-02-16

Brief Title: Odiparcil QT Definitive Study
Sponsor: GlaxoSmithKline
Organization: GlaxoSmithKline

Organization Data

Organization: GlaxoSmithKline
Class: INDUSTRY
Study ID: ITI103221
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: GlaxoSmithKline
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators